// App-Quantinova.ai

1600 : A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells

Researchers

Presenter

  • Elizabeth M. Matthew

Principal Investigators

  • Lanlan Zhou

  • Namrata Vijayvergia

  • Joseph J. Drabick

  • Cristina I. Truica

  • Zhaohai Yang

  • Wafik S. El-Deiry

  • David T. Dicker

  • Karen S. Gustafson

  • Harry S. Cooper

  • Eric A. Ross

  • Bora Lim

  • Ramdane Harouaka

  • Si-Yang Zheng

  • Nicholas E. Lamparella

Medical Centers

  • Department of Biomedical Engineering, Penn State University, University Park, PA

  • Fox Chase Cancer Center, Philadelphia, PA

  • Penn State Hershey Medical Center, Hershey, PA

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • Molecular Therapeuti

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Solid malignancies

  • Prostate cancer

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • Prostate specific antigen

  • Cytokeratin 20

  • Transcription termination factor 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final